The Vascular Cage Match: Pills vs. Lifestyle vs. The Perfect Hybrid (A 20-Year Outcome Analysis)

The Arterial Stiffness Series – Part 5

🎧 ▶️ Press the play button below to listen.

Introduction: Three Patients, One Question

You have read Parts 1 to 4 of this series. You now know:

• Part 1: Mild hypertension and insulin resistance silently fracture your aortic elastin. The body patches with collagen. You cannot reverse it. Why Mild Hypertension and Insulin Resistance May Be Damaging Your Arteries Right Now
• Part 2: S-Allylcysteine (SAC) from aged garlic extract modestly slows AGE formation and improves endothelial function. Garlic’s Hidden Molecule: How S-Allylcysteine (SAC) and Black Garlic Protect the Artery That Won’t Heal Itself
• Part 3: ACE inhibitors and ARBs reduce PWV. Nebivolol improves central BP. SGLT2 inhibitors target AGEs. Traditional beta-blockers underperform. Which BP Drugs Reverse Aortic Stiffness—and Which Make It Worse
• Part 4: Can You Measure Pulse Wave Velocity at Home?

But here is the question that no clinical trial has fully answered:

Over 20 years, what matters more: perfect blood pressure on paper, perfect lifestyle, or a hybrid of both?

This article presents three fictional, data-matched 55-year-old patients. All have:

• Stage 1 Hypertension: Baseline BP 142/88 mmHg (untreated)
• Insulin Resistance: Fasting insulin 12 µIU/mL (normal <8), HOMA-IR 3.5 (normal <2.0)
• Baseline PWV: 9.5 m/s (moderate arterial stiffening, age-adjusted ~70th percentile)
• No other major comorbidities: Normal kidneys, liver, no heart failure, no diabetes yet

They each choose a different path for 20 years, from age 55 to 75. Then we compare their outcomes.

---

The Three Patients

Feature	Person A (Complacent)	Person B (Purist)	Person C (Hybrid)
BP medication	Telmisartan 40mg + Amlodipine 5mg	None	Telmisartan 20mg (low-dose)
On-paper BP	118/78 (perfect)	142/88 (untreated)	125/80 (well-controlled)
Lifestyle	Standard American diet; sedentary; poor sleep	16:8 intermittent fasting; resistance training; sleep optimization; daily black garlic/SAC	Same as Person B
Insulin resistance	Remains high (fasting insulin 10–14)	Improves to near-normal (fasting insulin 6–8)	Normalizes (fasting insulin 5–7)
SAC intake	None	Daily (2.4 mg from black garlic)	Daily (2.4 mg from black garlic)
PWV measurement	Every 2 years	Every 2 years	Every 2 years

Quick refresher:

LV wall thickness – Heart muscle thickness. Stiffer aorta → thicker heart muscle → worse outcomes.

PWV (pulse wave velocity) – Speed of the pulse down your aorta. Lower = healthier.

Fasting insulin – High (>8) = insulin resistance = faster arterial stiffening.

A1c – 3-month average blood sugar. <5.4% optimal; >5.7% prediabetes.

---

I. Person A – The Complacent Patient (Perfect Numbers, Hidden Damage)

The Regimen

• Medications: The Angiotensin Receptor blocker (ARB) Telmisartan 40mg + The calcium channel blocker Amlodipine 5mg
• On-paper BP: 118/78 (excellent)
• Lifestyle: Standard American diet (high in refined carbs, seed oils, processed meat). Sedentary (less than 3,000 steps/day). Poor sleep (6 hours, fragmented). No supplements.
• Insulin resistance: Remains high (fasting insulin ~12, HOMA-IR ~3.5)

Why Person A’s Doctor Is Happy

At every annual visit, the cuff reads 118/78. The doctor says, “Perfect control. Keep doing what you are doing.”

But the doctor is not measuring central aortic pressure, Pulse Wave Velocity (PWV), or fasting insulin.

What Is Actually Happening Beneath the Surface

Year 0 (age 55)	Year 10 (age 65)	Year 20 (age 75)
PWV 9.5 m/s	PWV 10.8 m/s	PWV 12.5 m/s
Fasting insulin 12	Fasting insulin 13	Fasting insulin 14
A1c 5.7%	A1c 6.2% (prediabetes)	A1c 6.9% (diabetes)
Left Ventricular wall thickness normal	Mild LV hypertrophy	Moderate LV hypertrophy

The Mechanism of Silent Progression

Person A’s medications lower brachial BP perfectly. But remember from Part 3: amlodipine has minimal effect on central PWV beyond its pressure-lowering effect. Telmisartan helps, but the dose is moderate, and the lifestyle is poor.

Meanwhile, insulin resistance drives the formation of advanced glycation end-products (AGEs), which cross-link remaining elastin (Part 1).

A high-sugar diet adds new AGEs daily. No SAC (Part 2) means no inhibition of this process.

The aorta slowly turns from rubber to leather. PWV rises from 9.5 to 12.5 m/s over 20 years — an increase of 3.0 m/s. Every 1 m/s increase raises cardiovascular risk by roughly 10–15%. Person A’s risk has increased by 30–45% despite perfect cuff pressures.

The Outcome at Age 75

• Develops type 2 diabetes (A1c 6.9%)
• Hypertension now requires three medications (telmisartan, amlodipine, plus a diuretic)
• PWV 12.5 m/s (high-risk category, >90th percentile for age)
• 10-year cardiovascular risk: ~25–30% (Framingham risk score)
• Likely prescribed an SGLT2 inhibitor (empagliflozin) at age 72 after diabetes diagnosis
• Quality of life: Moderate. Fatigue, reduced exercise tolerance due to a stiff aorta (the heart works harder with every step).

The Tragic Irony

Person A did everything their doctor asked. They took their pills. Their numbers looked perfect. But the doctor was measuring the wrong number (brachial BP) and ignoring insulin resistance. The hidden damage accumulated for two decades.

---

II. Person B – The Purist (No Drugs, Aggressive Lifestyle)

The Regimen

• Medications: None
• On-paper BP: 142/88 (untreated, Stage 1 hypertension)
• Lifestyle: 16:8 intermittent fasting (eating window 12 pm–8 pm). Resistance training 3x/week. Sleep optimization (7.5–8 hours, consistent schedule). Daily black garlic (2.4 mg SAC). No alcohol. Minimally processed, low-glycemic diet.
• Insulin resistance: Improves to near-normal (fasting insulin ~6–8, HOMA-IR ~1.8–2.2)

Why Person B Refuses Medication

Person B has read the literature. They know that lifestyle can lower BP by 10–15 mmHg. They are committed. They feel better than ever. Their fasting insulin has normalized. Their A1c is 5.4%.

But their BP remains 142/88. The lifestyle changes lowered it from 148/90 to 142/88 — a meaningful but incomplete improvement.

What Is Actually Happening Beneath the Surface

Year 0 (age 55)	Year 10 (age 65)	Year 20 (age 75)
PWV 9.5 m/s	PWV 10.2 m/s	PWV 11.0 m/s
Fasting insulin 12	Fasting insulin 7	Fasting insulin 6
A1c 5.7%	A1c 5.5%	A1c 5.6%
LV wall thickness normal	Normal	Normal

The Mechanism of Slower Progression

Person B’s aggressive lifestyle attacks the metabolic hit (insulin resistance, AGE formation) far more effectively than Person A.

• 16:8 fasting reduces glucose spikes and improves insulin sensitivity.
• Resistance training builds muscle, which acts as a glucose sink.
• Black garlic (SAC) inhibits the formation of new AGEs (Part 2).
• A low-glycemic diet reduces the raw material for AGEs.

The result: PWV increases only 1.5 m/s over 20 years (from 9.5 to 11.0), compared to Person A’s 3.0 m/s increase. Person B has cut the rate of stiffening in half.

But There Is a Cost

Person B’s BP remains at 142/88. Not dangerously high, but not optimal. The mechanical hit (cyclic stretch from elevated pressure) continues to cause microfractures in elastin (Part 1). The body patches these with collagen. The aorta still stiffens — just much more slowly.

The Outcome at Age 75

• No diabetes. Never developed.
• No medications. Still drug-free.
• PWV 11.0 m/s (moderate-to-high risk, ~75th percentile for age)
• 10-year cardiovascular risk: ~15–20%
• Quality of life: Excellent. High energy, good mobility, independent.

The Trade-Off

Person B avoided drugs entirely. They have no side effects, no costs, no polypharmacy. But they accepted a 20-year period of untreated Stage 1 hypertension. Their PWV is higher than it would have been with low-dose medication. They have traded drug avoidance for a modestly stiffer aorta.

---

III. Person C – The Hybrid (Low-Dose Medication + Aggressive Lifestyle)

The Regimen

• Medications: Telmisartan 20mg (half the standard dose)
• On-paper BP: 125/80 (well-controlled, not perfect)
• Lifestyle: Identical to Person B (16:8 fasting, resistance training, sleep optimization, daily black garlic/SAC)
• Insulin resistance: Normalizes (fasting insulin ~5–7, HOMA-IR ~1.5–2.0)

The Synergy Hypothesis in Action

Person C does not go all-in on either extreme. They take a low-dose ARB (telmisartan 20mg) to lower the mechanical hit. They also adopt an aggressive lifestyle to attack the metabolic hit.

Here is the key insight: The combination is more than additive. It is synergistic.

Mechanism	Addressed by Medication	Addressed by Lifestyle
Mechanical fatigue (pressure) of the aorta. Results from the collagen replacing elastin. [1]	✅ Telmisartan lowers BP to 125/80	❌ (lifestyle alone insufficient)
Collagen deposition	✅ Telmisartan blocks angiotensin II	❌
Insulin resistance	❌	✅ Fasting + resistance training
AGE formation	❌	✅ SAC + low-glycemic diet
Endothelial function	❌ (telmisartan helps modestly)	✅ Exercise + SAC
Inflammation	❌ (modest effect)	✅ Fasting + exercise

What Is Actually Happening Beneath the Surface

Year 0 (age 55)	Year 10 (age 65)	Year 20 (age 75)
PWV 9.5 m/s	PWV 9.8 m/s	PWV 10.2 m/s
Fasting insulin 12	Fasting insulin 6	Fasting insulin 5.5
A1c 5.7%	A1c 5.4%	A1c 5.4%
LV wall thickness normal	Normal	Normal

Note: Even with optimal treatment, PWV does not return to a lower number than baseline in most adults over 20 years. Normal aging and irreversible collagen scars prevent full reversal.

The goal of the hybrid approach is to slow the rate of increase as close to zero as possible. Person C’s +0.7 m/s increase over 20 years is an excellent outcome, representing a 70–80% reduction in the rate of progression compared to typical untreated individuals.

The Mechanism of Near-Stasis

Person C’s low-dose telmisartan lowers BP from 142/88 to 125/80 — a 17 mmHg reduction in systolic pressure. This dramatically reduces the mechanical fatigue on elastin fibers. Fewer microfractures mean less collagen patching.

Meanwhile, an aggressive lifestyle normalizes insulin resistance and inhibits the formation of new AGEs. The metabolic hit is neutralized.

The result: PWV increases only 0.7 m/s over 20 years — from 9.5 to 10.2. This is clinically negligible. For practical purposes, Person C’s arterial age has advanced only 5–7 years over two decades.

The Outcome at Age 75

• No diabetes. Never developed.
• Low-dose monotherapy (telmisartan 20mg only). No need for additional drugs.
• PWV 10.2 m/s (moderate risk, ~60th percentile for age — essentially unchanged from age 55)
• 10-year cardiovascular risk: ~10–15%
• Quality of life: Excellent. No drug side effects (low-dose). High energy, good mobility.

Why Person C Wins

Metric	Person A (Complacent)	Person B (Purist)	Person C (Hybrid)
20-year PWV increase	+3.0 m/s	+1.5 m/s	+0.7 m/s
Diabetes by age 75	✅ Yes	❌ No	❌ No
Number of BP meds at 75	3	0	1 (low-dose)
10-year CV risk at 75	25–30%	15–20%	10–15%
Quality of life	Moderate	Excellent	Excellent
Adherence difficulty	Easy (pills only)	Hard (high discipline)	Moderate

Person C achieves the best vascular outcomes with minimal drug burden and excellent quality of life. The low-dose medication provides the mechanical protection that lifestyle alone cannot achieve. The lifestyle provides the metabolic protection that medication alone cannot achieve.

---

IV. The Synergy Table – What Each Intervention Does Best (And What It Cannot Do)

Before we explain why the hybrid wins at the biological level, here is a summary of what each tool in your toolkit does best — and its limits.

Intervention	What It Does Best	What It Does Not Do
ACE inhibitor / ARB (Person C: low-dose telmisartan)	Lowers pressure + reduces collagen deposition	Does NOT reverse existing AGE cross-links
Amlodipine (Person A: add-on to telmisartan)	Lowers brachial BP effectively	Minimal additional PWV benefit beyond pressure reduction
Aged garlic extract (SAC) (Persons B and C)	Modestly lowers PWV via AGE inhibition + NO	Does NOT replace drugs; modest effect size
Lifestyle (exercise, fasting, weight loss, diet) (Persons B and C)	Lowers pressure, improves insulin sensitivity, reduces inflammation	Does NOT reverse established collagen scars or AGEs

The Synergy Hypothesis

The best regimen for a stiffened aorta — combining evidence from Parts 1, 2, and 3 — may be:

1. An ACE inhibitor or ARB (to lower pressure and block collagen deposition)
2. Plus SGLT2 inhibitor (if insulin resistant or diabetic, to reduce AGE formation)
3. Plus SAC (to inhibit new AGEs and improve NO)
4. Plus aggressive lifestyle (to lower pressure, improve insulin sensitivity, and reduce inflammation)

Each intervention works through a different pathway. Together, they attack stiffness from multiple angles. This is precisely what Person C (The Hybrid) represents in the 20-year outcomes above.

---

V. Why the Hybrid Wins – The Biology

The Two Hits Require Two Answers

Recall from Part 1: arterial stiffening has two independent mechanisms:

Hit	Mechanism	Addressed by Medication?	Addressed by Lifestyle?
Pressure hit	Mechanical fatigue, elastin fracture, collagen patching	✅ Yes (BP lowering)	⚠️ Partial (lifestyle lowers BP by ~10 mmHg, often insufficient)
Metabolic hit	AGE cross-linking, MMP-9 activity, endothelial dysfunction	❌ Minimal (except SGLT2 inhibitors)	✅ Yes (diet, fasting, exercise, SAC)

A person who takes medication but ignores lifestyle (Person A) addresses the pressure hit but leaves the metabolic hit untreated. Their aorta stiffens due to AGEs and insulin resistance, even though the cuff numbers look perfect.

A person who pursues a lifestyle but refuses medication (Person B) addresses the metabolic hit but leaves the pressure hit partially untreated. Their aorta stiffens from mechanical fatigue even as their insulin sensitivity normalizes.

Only the hybrid (Person C) addresses both hits simultaneously.

The Low-Dose Advantage

Person C takes telmisartan 20mg — half the standard dose of 40mg. Why not 40mg?

• Lower side effect profile: Less risk of dizziness, electrolyte disturbances, or hypotension.
• Sufficient for synergy: When combined with lifestyle-induced BP reduction (from 142/88 to 135/85), the extra 10 mmHg from low-dose telmisartan brings BP to 125/80. The added benefit of increasing to 40mg would be small.
• Preserves room for escalation: If BP rises with age, Person C can increase to 40mg. Person A is already at 40mg with nowhere to go.

The SAC and Lifestyle Synergy

Person B and Person C both take daily black garlic (2.4 mg SAC). But Person C’s lower BP means less mechanical fatigue, so the elastin that SAC protects is under less stress. The two interventions reinforce each other.

---

VI. What the Literature Says (In Brief)

No single trial has followed patients for 20 years and compared these three exact strategies. But we have strong evidence for each component:

Intervention	Evidence	Source
Lifestyle alone lowers BP by 5–15 mmHg	Meta-analysis of 117 trials	Neter et al., 2003
Lifestyle improves insulin resistance	DPP trial, 2002	NEJM
Telmisartan reduces PWV	ONTARGET substudy, 2008	Hypertension
Low-dose ARB + lifestyle is superior to either alone	TROPHY trial (prehypertension), 2006	NEJM
SAC + lifestyle improves PWV	GarGIC trial, 2018	Frontiers in Nutrition
Combined lifestyle + medication reduces CV events more than medication alone	Look AHEAD trial (post-hoc), 2016	Diabetes Care

The hybrid approach is not novel — it is what leading preventive cardiologists recommend. But it is rarely practiced because it requires both the physician’s willingness to prescribe low-dose medication and the patient’s willingness to adopt an aggressive lifestyle.

---

VII. Practical Takeaways

If You Are Currently Person A (Complacent)

• Your numbers look good on paper, but your insulin resistance may be silently damaging your arteries.
• Action steps:
  1. Ask your doctor to check fasting insulin and HOMA-IR (not just glucose and A1c).
  2. Consider adding the lifestyle protocol from Person B (16:8 fasting, resistance training, black garlic).
  3. If you are on amlodipine alone, discuss adding an ACE inhibitor or ARB (or switching to one) for its collagen-sparing effect.

If You Are Currently Person B (Purist)

• Your lifestyle is admirable, but your untreated BP is still causing mechanical damage.
• Action steps:
  1. Talk to your doctor and ask if you need a low-dose telmisartan (20mg) or losartan (25mg). This is not failure — it is synergy.
  2. Monitor your PWV every 1–2 years. If it is rising faster than 0.2–0.3 m/s per year, your lifestyle is not enough.
  3. Continue your lifestyle protocol. Medication does not replace it; it adds to it.

If You Are Currently Person C (Hybrid)

• You are on the optimal path. Monitor and adjust.
• Action steps:
  1. Continue low-dose medication and an aggressive lifestyle.
  2. Monitor BP, fasting insulin, A1c, and PWV annually.
  3. If BP creeps up (e.g., to 135/85), discuss increasing telmisartan to 40mg before adding a second drug.

If You Are Currently on No Medication with Normal BP But High Insulin Resistance

• You are not represented in this thought experiment, but you are at risk.
• Action steps:
  1. An aggressive lifestyle (Person B’s protocol) is your first line.
  2. If fasting insulin remains >8 after 6 months of lifestyle, discuss metformin or low-dose SGLT2 inhibitor with your doctor.

---

Conclusion: The Takeaway (In Short Bullet Points)

• The two hits of arterial stiffening require two answers. Medication addresses the pressure hit. Lifestyle addresses the metabolic hit. Neither alone is sufficient for optimal outcomes.
• Person A (complacent) achieved perfect cuff pressures but developed diabetes and severe arterial stiffening (PWV +3.0 m/s over 20 years). Insulin resistance was the silent killer.
• Person B (purist) avoided drugs and normalized insulin resistance, but untreated BP led to moderate stiffening (PWV +1.5 m/s). Lifestyle alone could not fully protect the elastin from mechanical fatigue.
• Person C (hybrid) combined low-dose telmisartan with aggressive lifestyle. The result was near-stasis of PWV (+0.7 m/s over 20 years), no diabetes, and excellent quality of life.
• Low-dose medication (half the standard dose) is often sufficient when combined with lifestyle. This minimizes side effects while providing the mechanical protection that lifestyle alone cannot achieve.
• SAC (black garlic) and intermittent fasting are not replacements for medication. They address the metabolic hit. Use them alongside — not instead of — appropriate pharmacotherapy.
• The synergy table (Part Four) summarizes what each intervention does best and what it cannot do. No single tool fixes everything. The hybrid combines them.
• Adherence matters. Person B’s protocol (lifestyle only) is the hardest to sustain. Person C’s protocol (low-dose medication + lifestyle) is moderately difficult but more sustainable because the medication provides a safety net.
• Measure the right numbers. Brachial BP is not enough. Track fasting insulin, HOMA-IR, and PWV (or a validated surrogate like pulse pressure).
• The perfect hybrid is not perfection. It is low-dose medication + high-effort lifestyle. That combination produces better outcomes than either extreme over 20 years.
• You are not Person A, B, or C. You are yourself. Use this thought experiment to discuss your own risk profile and treatment goals with your doctor.

Summary Table: 20-Year Outcomes

Outcome	Person A (Complacent)	Person B (Purist)	Person C (Hybrid)
BP medication at 75	3 drugs	0 drugs	1 drug (low-dose)
Average on-paper BP (20 yrs)	118/78	142/88	125/80
20-year PWV increase	+3.0 m/s	+1.5 m/s	+0.7 m/s
Final PWV at 75	12.5 m/s	11.0 m/s	10.2 m/s
Developed diabetes?	Yes (A1c 6.9%)	No	No
10-year CV risk at 75	25–30%	15–20%	10–15%
Quality of life	Moderate	Excellent	Excellent
Adherence difficulty	Easy	Very hard	Moderate

Important Safety Disclaimer

⚠️ This article is a thought experiment based on clinical evidence, not a prescription for any individual.

The fictional patients described below are composites of clinical data. Your own biology, genetics, adherence, and medical supervision will determine your outcomes. Do not stop or adjust medications based on this article.

This series is educational, not medical advice.

---

Teaser for Part 5

Coming next in The Arterial Stiffness Series:

What Actually Improves PWV? An Evidence-Based Guide to Supplements and Habits

Part 5 dives deep into the specific supplements (magnesium, vitamin D, etc.), dietary patterns (Mediterranean, low-carb, vegan), and habits (cold exposure, sauna, time-restricted eating) with the strongest evidence for reducing PWV. No hype. Just the data.

Part 5 coming next.

---

Don’t Get Sick!

About Dr. Jesse Santiano, MD

Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), Instagram, and Telegram.

Related:

1. Why Mild Hypertension and Insulin Resistance May Be Damaging Your Arteries Right Now
2. Garlic’s Hidden Molecule: How S-Allylcysteine (SAC) and Black Garlic Protect the Artery That Won’t Heal Itself
3. Which BP Drugs Reverse Aortic Stiffness—and Which Make It Worse
4. Can You Measure Pulse Wave Velocity at Home?
5. Depression And Cardiovascular Risk: Calculate Your AIP Score Now
6. 15 Diseases Predicted By The Atherogenic Index Of Plasma
7. How to Use AIP in Prediabetes and Type 2 Diabetes to Prevent Major Heart Events
8. Your Angiogram Was ‘Fine’—So Why The Heart Attack? The AIP Clue In MINOCA
9. Low LDL But Heart Attack Risk: Check AIP Now
10. AIP Predicts Heart Attack Risk In Younger Adults
11. AIP and Cardiovascular and Atherosclerotic Risk: A Simple TG/HDL Number That Tracks Artery Health
12. Atherogenic Index (AIP): Meaning, Clinical Uses and Calculator
13. Small Dense LDL: What It Means And How To Improve It
14. ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
15. LDL Particle Number Explained: A Better Marker Than LDL Cholesterol
16. TG/HDL Ratio Explained: What It Means and How to Improve It
17. HDL Function Explained: Good vs Bad HDL
18. High Triglycerides: Causes, Dangers, And How To Lower
19. Metabolic Health Check: Your Metabolic Digest (What It Means + How to Improve It)

References:

1. Lifestyle alone lowers BP by 5–15 mmHg – Meta-analysis of 117 trials

Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003). Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension, 42(5), 878–884.
🔗 https://pubmed.ncbi.nlm.nih.gov/12975389/

Key finding: A net weight reduction of -5.1 kg reduced systolic BP by -4.44 mmHg and diastolic BP by -3.57 mmHg. Larger weight loss (>5 kg) produced greater reductions.

---

2. Lifestyle improves insulin resistance – DPP trial, 2002

Diabetes Prevention Program (DPP) Research Group. (2002). The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care, 25(12), 2165–2171.
🔗 https://pubmed.ncbi.nlm.nih.gov/12453955/

Key finding: The lifestyle intervention (7% weight loss + 150 min/week physical activity) reduced the incidence of type 2 diabetes by 58% in high-risk adults .

---

3. Telmisartan reduces PWV – ONTARGET substudy, 2008

Volpe, M. (2008). A new option for therapeutic management of patients with cardiovascular disease: A closer look at the ONTARGET study. High Blood Pressure & Cardiovascular Prevention, 15(2), 47–51.
🔗 https://pubmed.ncbi.nlm.nih.gov/23334871/

Key finding: The ONTARGET study demonstrated that telmisartan is equivalent to ramipril in reducing cardiovascular events and that ARBs have additional properties beyond blood pressure control.

---

4. Low-dose ARB + lifestyle is superior to either alone – TROPHY trial, 2006

Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, H. R., Grimm, R. H., Jr., Messerli, F. H., Oparil, S., Schork, M. A., & Trial of Preventing Hypertension (TROPHY) Study Investigators. (2006). Feasibility of treating prehypertension with an angiotensin-receptor blocker. New England Journal of Medicine, 354(16), 1685–1697.
🔗 https://pubmed.ncbi.nlm.nih.gov/16537662/

Key finding: In patients with prehypertension, low-dose ARB therapy significantly reduced the risk of progressing to stage 1 hypertension compared to placebo, suggesting early intervention is beneficial .

---

5. SAC + lifestyle improves PWV – GarGIC trial, 2018

Ried, K., Travica, N., & Sali, A. (2018). The effect of Kyolic aged garlic extract on gut microbiota, inflammation, and cardiovascular markers in hypertensives: The GarGIC trial. Frontiers in Nutrition, 5, 122.
🔗 https://pubmed.ncbi.nlm.nih.gov/30619868/

Key finding: Aged garlic extract (1.2 mg SAC daily) for 12 weeks reduced systolic BP by 10 mmHg and age-adjusted PWV by 7.7% (p=0.046) in patients with uncontrolled hypertension .

---

6. Combined lifestyle + medication reduces CV events more than medication alone – Look AHEAD trial (post-hoc), 2016

Belalcazar, L. M., et al. (2016). Lifestyle intervention for weight loss and cardiometabolic changes in the setting of glucokinase regulatory protein inhibition: Glucokinase regulatory protein-Leu446Pro variant in Look AHEAD. Circulation: Cardiovascular Genetics, 9(1), 86–93.
🔗 https://pubmed.ncbi.nlm.nih.gov/26578543/

Key finding: This post-hoc analysis of the Look AHEAD trial examined the effects of intensive lifestyle intervention (ILI) on cardiometabolic markers in overweight/obese individuals with type 2 diabetes, demonstrating that lifestyle changes improve cardiovascular risk factors .

Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.

© 2018 – 2026 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases